Play all audios:
Access through your institution Buy or subscribe “This technology holds incredibly great promise for [boosting] the world's food supply,” says Bernadette Dunham, who directs the FDA
Center for Veterinary Medicine. Despite that favorable take on the technology, the regulatory review of the fish is continuing, with no decision rendered. FDA officials made scrupulous
efforts to explain the regulatory hoops through which the AquAdvantage salmon had to leap. But to consumer and environmental groups, activists and sundry other critics of this transgenic
salmon, the FDA review process proved unpersuasive to some, and outright fishy to others. Qualms over the regulatory evaluation have also been voiced by at least ten US Senators and several
members of the US House of Representatives. “There are a number of serious concerns with the current approval process and many potential human health and environmental risks that are
associated with producing GE [genetically engineered] fish have not been fully or openly reviewed,” they noted in a letter to FDA commissioner Margaret Hamburg. The members of Congress are
insistent that the new transgenic species undergo a formal evaluation by the FDA's Center for Food Safety and Applied Nutrition so that its potential health effects on humans be
assessed. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online
access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which
are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support AUTHOR INFORMATION AUTHORS AND
AFFILIATIONS * Washington, DC Jeffrey L Fox Authors * Jeffrey L Fox View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and
permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fox, J. Transgenic salmon inches toward finish line. _Nat Biotechnol_ 28, 1141–1142 (2010). https://doi.org/10.1038/nbt1110-1141a Download
citation * Published: 05 November 2010 * Issue Date: November 2010 * DOI: https://doi.org/10.1038/nbt1110-1141a SHARE THIS ARTICLE Anyone you share the following link with will be able to
read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing
initiative